Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution
Vanessa D. Jönsson(California Institute of Technology), Trever G. Bivona(University of California, San Francisco)
Cited by 34
Related Papers
Targeting Oncogenic BRAF: Past, Present, and Future
|Cancers|2019|241
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
|Nature Communications|2024|84
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer
|Journal of Clinical Investigation|2022|53
Heterogeneity and targeted therapy-induced adaptations in lung cancer revealed by longitudinal single-cell RNA sequencing
|bioRxiv (Cold Spring Harbor Laboratory)|2019|10
Synthetic essentiality of metabolic regulator PDHK1 in PTEN-deficient cells and cancers
|bioRxiv (Cold Spring Harbor Laboratory)|2018|5